Brief: Chinook Therapeutics Reports Qtrly Loss Per Share Of $0.69

Chinook Therapeutics

08/11/2021 14:25

Nov 8 (Reuters) - Chinook Therapeutics Inc  KDNY.O :
    * CHINOOK THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS
THIRD
QUARTER 2021 FINANCIAL RESULTS
    * QTRLY LOSS PER SHARE $0.69
    * CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES TOTALED
$204.8
MILLION AT SEPTEMBER 30, 2021
    * TOTAL REVENUE INCREASED BY LESS THAN $0.1 MILLION FOR Q3
OF 2021
    * Q3 EARNINGS PER SHARE VIEW $-0.84, REVENUE VIEW $41670.00
--
REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX3klsVn 
Further company coverage:  KDNY.O 

 ((Reuters.Briefs@thomsonreuters.com;))